Nephro Care India Limited Stock Price Today (NSE: NEPHROCARE)
Fundamental Score
Nephro Care India Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Nephro Care India Limited share price today is ₹86.00, up +0.70% on NSE/BSE as of 16 October 2026. Nephro Care India Limited (NEPHROCARE) is a Small-cap company in the Hospital sector with a market capitalisation of ₹108.73 (Cr). The 52-week high for NEPHROCARE share price is ₹156.35 and the 52-week low is ₹51.65. At a P/E ratio of 32.26x, NEPHROCARE is currently trading below its industry average P/E of 48.79x. The company has a Return on Equity (ROE) of 6.11% and a debt-to-equity ratio of 0.00.
Nephro Care India Limited Share Price Chart — NSE/BSE Historical Performance
Nephro Care India Limited share price chart: -10.28% return over the past month. 52-week high ₹156.35, 52-week low ₹51.65.
Nephro Care India Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹85.00 | ₹86.95 | ₹83.10 | ₹86.00 | 4.40K (Cr) | |
| ₹85.70 | ₹87.45 | ₹85.05 | ₹85.40 | 9.60K (Cr) | |
| ₹88.00 | ₹88.00 | ₹82.60 | ₹85.70 | 37.60K (Cr) | |
| ₹86.00 | ₹87.60 | ₹85.00 | ₹86.50 | 9.60K (Cr) | |
| ₹84.00 | ₹87.70 | ₹83.15 | ₹83.85 | 22.00K (Cr) | |
| ₹82.70 | ₹84.95 | ₹82.05 | ₹83.95 | 16.40K (Cr) | |
| ₹85.00 | ₹85.90 | ₹80.00 | ₹82.80 | 30.80K (Cr) | |
| ₹87.40 | ₹88.45 | ₹84.15 | ₹84.75 | 31.20K (Cr) | |
| ₹86.90 | ₹89.90 | ₹84.95 | ₹87.30 | 27.20K (Cr) | |
| ₹92.00 | ₹92.00 | ₹85.00 | ₹86.90 | 29.20K (Cr) |
Nephro Care India Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹90.65 | ₹92.00 | ₹80.00 | ₹86.00 | -5.13% | |
| ₹102.40 | ₹104.95 | ₹78.00 | ₹90.65 | -11.47% | |
| ₹64.00 | ₹107.70 | ₹62.00 | ₹101.85 | +59.14% | |
| ₹70.60 | ₹70.60 | ₹60.50 | ₹64.25 | -8.99% | |
| ₹68.85 | ₹71.00 | ₹68.85 | ₹68.85 | +0.00% | |
| ₹80.50 | ₹88.00 | ₹78.00 | ₹80.25 | -0.31% | |
| ₹55.90 | ₹88.90 | ₹53.00 | ₹88.60 | +58.50% | |
| ₹63.50 | ₹63.50 | ₹51.65 | ₹52.30 | -17.64% | |
| ₹101.20 | ₹116.05 | ₹70.00 | ₹82.45 | -18.53% | |
| ₹112.25 | ₹123.00 | ₹95.00 | ₹100.20 | -10.73% | |
| ₹131.20 | ₹131.40 | ₹107.50 | ₹110.50 | -15.78% | |
| ₹131.95 | ₹156.35 | ₹131.95 | ₹148.00 | +12.16% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Nephro Care India Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Nephro Care India Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of NEPHROCARE across key market metrics for learning purposes.
Positive Indicators
8 factors identified
Attractive Valuation (P/E: 32.26 vs Industry: 48.79)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Consistent Growth Track Record (117.57% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Strong Profit Growth Track Record (106.38% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (30.00x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Healthy Liquidity Position (Current Ratio: 2.01)
Observation: Strong short-term liquidity to meet obligations.
Analysis: Current ratio >1.5 indicates good working capital management.
Balanced Promoter Holding (61.71%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
6 factors identified
Below-Average Return on Equity (6.11%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (8.70%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Weak Earnings Growth (-53.09% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Negative Free Cash Flow (₹-28.61 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 2.03%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Nephro Care India Limited vs Hospital Peers
Peer Comparison - Hospital
Compare Nephro Care India Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
42.4/100 | ₹86.00₹86 | ₹108.73₹108.73 | 32.26Average 32.3 Average | 6.11%Poor 6.11% Poor | 8.70%Poor 8.70% Poor | 0.00Excellent 0.0 Excellent | 106.38%Excellent 106.38% Excellent | 117.57%Excellent 117.57% Excellent | 0.00% | |
Apollo Hospitals Enterprise LimitedApollo Hospital... APOLLOHOSP • 508869 | 64.1/100 | ₹7890.00₹7890 | ₹113458.20₹113458.20 | 54.29Average 54.3 Average | 21.95%Excellent 21.95% Excellent | 19.28%Good 19.28% Good | 0.60Good 0.6 Good | 66.81%Excellent 66.81% Excellent | 19.03%Excellent 19.03% Excellent | 0.22% |
Max Healthcare Institute LimitedMax Healthcare ... MAXHEALTH • 543220 | 55.5/100 | ₹846.00₹846 | ₹82336.10₹82336.10 | 56.44Average 56.4 Average | 14.33%Average 14.33% Average | 13.43%Average 13.43% Average | 0.32Excellent 0.3 Excellent | 60.01%Excellent 60.01% Excellent | 27.30%Excellent 27.30% Excellent | 0.18% |
Fortis Healthcare LimitedFortis Healthca... FORTIS • 532843 | 50.6/100 | ₹736.50₹737 | ₹55602.80₹55602.80 | 53.06Average 53.1 Average | 11.08%Average 11.08% Average | 12.83%Average 12.83% Average | 0.29Excellent 0.3 Excellent | 64.38%Excellent 64.38% Excellent | 17.76%Excellent 17.76% Excellent | 0.10% |
Narayana Hrudayalaya Ltd.Narayana Hruday... NH • 539551 | 65.7/100 | ₹1719.40₹1719 | ₹35137.83₹35137.83 | 42.79Average 42.8 Average | 19.74%Good 19.74% Good | 14.53%Average 14.53% Average | 1.07Average 1.1 Average | 155.30%Excellent 155.30% Excellent | 25.05%Excellent 25.05% Excellent | 0.22% |
Aster DM Quality Care LimitedAster DM Qualit... ASTERDM • 540975 | 49.5/100 | ₹674.35₹674 | ₹34940.10₹34940.10 | 109.12Average 109.1 Average | 9.70%Poor 9.70% Poor | 11.35%Average 11.35% Average | 0.15Excellent 0.2 Excellent | 21.31%Excellent 21.31% Excellent | -11.61%Poor -11.61% Poor | 0.61% |
Global Health LimitedGlobal Health L... MEDANTA • 543654 | 57.9/100 | ₹1240.00₹1240 | ₹33327.48₹33327.48 | 59.90Average 59.9 Average | 15.15%Good 15.15% Good | 16.85%Good 16.85% Good | 0.30Excellent 0.3 Excellent | 80.71%Excellent 80.71% Excellent | 24.97%Excellent 24.97% Excellent | 0.04% |
27.7/100 | ₹685.60₹686 | ₹28795.20₹28795.20 | 134.43Average 134.4 Average | 11.01%Average 11.01% Average | 9.35%Poor 9.35% Poor | 1.44Average 1.4 Average | 3.71%Average 3.71% Average | 24.04%Excellent 24.04% Excellent | 0.00% | |
Dr. Agarwal's Health Care LimitedDr. Agarwal's H... AGARWALEYE • 544350 | 57.3/100 | ₹465.80₹466 | ₹14765.86₹14765.86 | 99.32Average 99.3 Average | 6.84%Poor 6.84% Poor | 10.16%Average 10.16% Average | 0.08Excellent 0.1 Excellent | 34.42%Excellent 34.42% Excellent | 34.58%Excellent 34.58% Excellent | 0.00% |
Rainbow Childrens Medicare LimitedRainbow Childre... RAINBOW • 543524 | 73/100 | ₹1248.90₹1249 | ₹12684.58₹12684.58 | 44.43Average 44.4 Average | 17.86%Good 17.86% Good | 18.10%Good 18.10% Good | 0.00Excellent 0.0 Excellent | 44.04%Excellent 44.04% Excellent | 21.24%Excellent 21.24% Excellent | 0.23% |
Yatharth Hospital & Trauma Care Services LimitedYatharth Hospit... YATHARTH • 543950 | 66.1/100 | ₹992.10₹992 | ₹9559.28₹9559.28 | 52.77Average 52.8 Average | 9.98%Poor 9.98% Poor | 12.29%Average 12.29% Average | 0.14Excellent 0.1 Excellent | 57.39%Excellent 57.39% Excellent | 41.18%Excellent 41.18% Excellent | 0.00% |
Top Hospital Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Apollo Hospitals Enterprise Limited share price113458.20 Cr
- Max Healthcare Institute Limited share price82336.10 Cr
- Fortis Healthcare Limited share price55602.80 Cr
- Narayana Hrudayalaya Ltd. share price35137.83 Cr
- Aster DM Quality Care Limited share price34940.10 Cr
Nephro Care India Limited PE Ratio History
Historical price-to-earnings ratio for NEPHROCARE — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2024 | ₹2.73 | ₹184.00 | 67.4x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Nephro Care India Limited Quarterly Performance
Latest quarterly metrics for NEPHROCARE — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
N/A
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
N/A
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
117.57%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
106.38%
Compounded annual net profit growth over 5 years
Nephro Care India Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for NEPHROCARE — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Nephro Care India Limited Financial Statements
Annual income statement, balance sheet and cash flow for Nephro Care India Limited (NEPHROCARE) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Nephro Care India Limited
About NEPHROCARE (Nephro Care India Limited)
Nephro Care India Limited (NEPHROCARE) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Hospital sector with a c...urrent market capitalisation of ₹108.73 (Cr). Nephro Care India Limited has delivered a Return on Equity (ROE) of 6.11% and a ROCE of 8.70%. The debt-to-equity ratio stands at 0.00, reflecting the company's capital structure. Investors tracking NEPHROCARE share price can monitor key metrics including P/E ratio, promoter holding of 61.71%, and quarterly earnings growth.
Company Details
NEPHROCARE Share Price: Frequently Asked Questions
What is the current share price of Nephro Care India Limited?
Nephro Care India Limited (NEPHROCARE) trades at ₹86.00 on NSE. Market cap ₹108.73 (Cr). Educational data only.
What is the P/E ratio of Nephro Care India Limited?
Nephro Care India Limited has a P/E of 32.26x vs industry average 48.79x.
What is the Bull Run score for Nephro Care India Limited?
Nephro Care India Limited has a Bull Run score of 42.4/100 based on 25+ financial parameters.
Does Nephro Care India Limited pay dividends?
Nephro Care India Limited has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Nephro Care India Limited?
Nephro Care India Limited has ROE of 6.11%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Nephro Care India Limited?
Nephro Care India Limited has debt-to-equity of 0.00.
Is Nephro Care India Limited a good investment?
Bull Run gives Nephro Care India Limited a score of 42.4/100. This is not investment advice — consult a SEBI-registered advisor.